SEC Form 4 · accession 0001274644-16-000073
Ocera Therapeutics, Inc. · OCRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eckard Weber
Director
Period of report
Jan 4, 2016
Accepted (ET)
Jan 6, 2016 · 4:03 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001274644
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 4, 2016 | M | 11,969 | $0.92 | A | 356,688 | D | |
| Common StockF1 | Jan 4, 2016 | G | 11,969 | $0.00 | D | 344,719 | D | |
| Common Stock | holding | — | — | — | 11,969 | I | By Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $0.92 | Jan 4, 2016 | M | 11,969 | A | — | Feb 6, 2016 | Common Stock | 11,969 | 0 | D |
Explanation of responses
- F1Represents transfer of shares to Eckard Weber Living Trust.
- F2The option is fully vested.